Low bone mass in microscopic colitis

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Lorinczy, Katalin ^a   Lakatos, Gábor ^a   Müllner, Katalin ^a   Hritz, István ^a   Lakatos, Péter L ^a   Tulassay, Zsolt ^a   Miheller, Pál ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Bone microscopic colitis; Crohn's disease; Osteoporosis

Indexed keywords

AZATHIOPRINE; MESALAZINE; OSTEOCALCIN;

ADULT; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; FEMUR NECK; HUMAN; LUMBAR SPINE; MALE; MICROSCOPIC COLITIS; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; RADIUS; BLOOD; BONE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; SPINE;

ABSORPTIOMETRY, PHOTON; ADULT; BONE AND BONES; BONE DENSITY; BONE RESORPTION; COLITIS, MICROSCOPIC; CROHN DISEASE; FEMALE; FEMUR NECK; HUMANS; MALE; MIDDLE AGED; OSTEOCALCIN; RADIUS; SPINE;

EID: 79956007512     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-58     Document Type: Article

References (37)

1. Tysk C, Bohr J, Nyhlin N, Wickbom A, Eriksson S. Diagnosis and management of microscopic colitis. World J Gastroenterol 2008, 14:7280-7288. 10.3748/wjg.14.7280, 2778111, 19109861.
2. Tangri V, Chande N. Microscopic colitis: an update. J Clin Gastroenterol 2009, 43:293-296. 10.1097/MCG.0b013e31818f50ce, 19169149.
3. Aigner T, Neureiter D, Muller S, Kuspert G, Belke J, Kirchner T. Extracellular matrix composition and gene expression in collagenous colitis. Gastroenterology 1997, 113:136-143. 10.1016/S0016-5085(97)70088-X, 9207271.
4. Bohr J, Nordfelth R, Jarnerot G, Tysk C. Yersinia species in collagenous colitis: a serologic study. Scand J Gastroenterol 2002, 37:711-714. 10.1080/00365520212509, 12126251.
5. Giardiello FM, Hansen FC, Lazenby AJ, Hellman DB, Milligan FD, Bayless TM, Yardley JH. Collagenous colitis in setting of nonsteroidal antiinflammatory drugs and antibiotics. Dig Dis Sci 1990, 35:257-260. 10.1007/BF01536772, 2302984.
6. Lindstrom CG. 'Collagenous colitis' with watery diarrhoea--a new entity?. Pathol Eur 1976, 11:87-89.
7. Lazenby AJ, Yardley JH, Giardiello FM, Jessurun J, Bayless TM. Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 1989, 20:18-28. 10.1016/0046-8177(89)90198-6, 2912870.
8. Lee E, Schiller LR, Vendrell D, Santa Ana CA, Fordtran JS. Subepithelial collagen table thickness in colon specimens from patients with microscopic colitis and collagenous colitis. Gastroenterology 1992, 103:1790-1796.
9. Kao KT, Pedraza BA, McClune AC, Rios DA, Mao YQ, Zuch RH, Kanter MH, Wirio S, Conteas CN. Microscopic colitis: a large retrospective analysis from a health maintenance organization experience. World J Gastroenterol 2009, 15:3122-3127. 10.3748/wjg.15.3122, 2705734, 19575491.
10. Chatelain D, Mokrani N, Flejou JF. [Microscopic colitis: collagenous colitis and lymphocytic colitis]. Ann Pathol 2007, 27:448-458. 10.1016/S0242-6498(07)71417-7, 18554555.
11. van Tilburg AJ, Lam HG, Seldenrijk CA, Stel HV, Blok P, Dekker W, Meuwissen SG. Familial occurrence of collagenous colitis. A report of two families. J Clin Gastroenterol 1990, 12:279-285. 10.1097/00004836-199006000-00009, 2362097.
12. Jarnerot G, Hertervig E, Granno C, Thorhallsson E, Eriksson S, Tysk C, Hansson I, Bjorknas H, Bohr J, Olesen M, et al. Familial occurrence of microscopic colitis: a report on five families. Scand J Gastroenterol 2001, 36:959-962.
13. Chande N, McDonald JW, Macdonald JK. Interventions for treating lymphocytic colitis. Cochrane Database Syst Rev 2007, CD006096.
14. O'Beirne JP, Ireland A. Progression of collagenous colitis to Crohn's disease. Eur J Gastroenterol Hepatol 2005, 17:573-575. 10.1097/00042737-200505000-00015, 15827449.
15. Janczewska I, Stal P, Sandstedt B. [Transformation of microscopic colitis to inflammatory bowel disease]. Lakartidningen 2007, 104:1597-1598.
16. Aqel B, Bishop M, Krishna M, Cangemi J. Collagenous colitis evolving into ulcerative colitis: a case report and review of the literature. Dig Dis Sci 2003, 48:2323-2327.
17. Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut 2004, 53:536-541. 10.1136/gut.2003.023440, 1774011, 15016748.
18. Compston JE, Judd D, Crawley EO, Evans WD, Evans C, Church HA, Reid EM, Rhodes J. Osteoporosis in patients with inflammatory bowel disease. Gut 1987, 28:410-415. 10.1136/gut.28.4.410, 1432817, 3583068.
19. Szathmari M, Pronai L, Tulassay Z. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 1998, 93:848-849.
20. Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med 2000, 247:63-70. 10.1046/j.1365-2796.2000.00582.x, 10672132.
21. van Staa TP, Cooper C, Brusse LS, Leufkens H, Javaid MK, Arden NK. Inflammatory bowel disease and the risk of fracture. Gastroenterology 2003, 125:1591-1597. 10.1053/j.gastro.2003.09.027, 14724810.
22. Moschen AR, Kaser A, Enrich B, Ludwiczek O, Gabriel M, Obrist P, Wolf AM, Tilg H. The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. Gut 2005, 54:479-487. 10.1136/gut.2004.044370, 1774465, 15753532.
23. Miheller P, Muzes G, Zagoni T, Toth M, Racz K, Tulassay Z. Infliximab therapy improves the bone metabolism in fistulizing Crohn's disease. Dig Dis 2006, 24:201-206. 10.1159/000091299, 16699279.
24. Dilger K, Alberer M, Busch A, Enninger A, Behrens R, Koletzko S, Stern M, Beckmann C, Gleiter CH. Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease. Aliment Pharmacol Ther 2006, 23:387-396. 10.1111/j.1365-2036.2006.02771.x, 16422998.
25. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976, 70:439-444.
26. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000, 6:8-15.
27. World Health Organization. Assessment of Fracture Risk and Application to Screening for Postmenopausal Osteoporosis. 1994, Geneva, Switzerland: World Health Organization.
28. Lian JB, Gundberg CM. Osteocalcin. Biochemical considerations and clinical applications. Clin Orthop Relat Res 1988, 226:267-291.
29. Okabe R, Nakatsuka K, Inaba M, Miki T, Naka H, Masaki H, Moriguchi A, Nishizawa Y. Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a new assay for degradation products of type I collagen C-tlopeptides. Clin Chem 2001, 47:1410-1414.
30. Bernstein CN, Leslie WD, Leboff MS. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 2003, 124:795-841. 10.1053/gast.2003.50106, 12612917.
31. Bernstein CN KS. Guidelines for osteoporosis and inflammatory bowel disease. Aguide to diagnosis and management for the gastroenterologist (monograph). The American College of Gastroenterology 2003,
32. Miheller P, Muzes G, Racz K, Blazovits A, Lakatos P, Herszenyi L, Tulassay Z. Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy. Inflamm Bowel Dis 2007, 13:1379-1384. 10.1002/ibd.20234, 17663430.
33. Miheller P, Toth M, Molnar E, Zagoni T, Racz K, Tulassay Z. [Serum bone marker measurements in bone metabolism disorders associated with inflammatory bowel diseases]. Orv Hetil 2001, 142:1557-1560.
34. Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. J Clin Invest 1999, 104:895-901. 10.1172/JCI6730, 408552, 10510330.
35. Vico L, Vanacker JM. Sex hormones and their receptors in bone homeostasis: insights from genetically modified mouse models. Osteoporos Int 2009, 1:365-72.
36. Klaus J, Reinshagen M, Adler G, Boehm B, von Tirpitz C. Bones and Crohn's: estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral density. BMC Gastroenterol 2008, 8:48. 10.1186/1471-230X-8-48, 2577678, 18947388.
37. Robinson RJ, Iqbal SJ, Al-Azzawi F, Abrams K, Mayberry JF. Sex hormone status and bone metabolism in men with Crohn's disease. Aliment Pharmacol Ther 1998, 12:21-25. 10.1046/j.1365-2036.1998.00271.x, 9692696.